| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President/ CEO | President, CEO
1 company
Gilad Oren is a President/ CEO at Aprea Therapeutics, Inc.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $316K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | APRE Aprea Therapeutics, Inc. | President/ CEO | Buy | 5,500 | $1.84 | $10,110.21 | +0.8% | -5.6% | -60.3% | |
| Oct 23, 2024 | APRE Aprea Therapeutics, Inc. | President/ CEO | Buy | 500 | $3.92 | $1,957.50 | +0.2% | +3.8% | -61.0% | |
| Oct 15, 2024 | APRE Aprea Therapeutics, Inc. | President/ CEO | Buy | 250 | $2.90 | $725.00 | - | +12.1% | -51.1% | |
| Oct 14, 2024 | APRE Aprea Therapeutics, Inc. | President/ CEO | Buy | 1,150 | $2.58 | $2,971.00 | +0.2% | +33.6% | -41.0% | |
| Mar 13, 2024 | APRE Aprea Therapeutics, Inc. | President, CEO | Buy | 2,000 | $7.29 | $14,580.00 | +0.6% | -19.6% | -57.2% |